Article |

Iatrogenic Osteoporosis

K. Lea Sewell, MD
Arch Dermatol. 1995;131(11):1321-1322. doi:10.1001/archderm.1995.01690230101016.
Text Size: A A A
Published online

BONE IS a vital, metabolically active tissue that may suffer when medications interfere with normal homeostatic processes. Because of the measured pace of bone turnover, clinically significant bone damage becomes a relevant risk for patients who are receiving medications recurrently or on a long-term basis. Drugs that are incorporated directly into bone have persistent effects long after discontinuation of treatment; eg, the elimination half-life for geminal bisphosphonates is approximately one decade.1 In assessing the potential mechanisms for bone damage, dermatologists should use an algorithm based on their knowledge of bone turnover and growth patterns. A precise delineation of a drug's interference with normal bone metabolism can guide both therapeutic and preventative measures.

NORMAL BONE REMODELING AND TURNOVER  Bone turnover occurs continuously within the framework of a tightly integrated process termed the bone multicellular unit.2 Osteoclast activation is the initial triggering event for all bone remodeling and is primarily


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.